We recently conducted a comprehensive review of the psychiatric inclusion and exclusion criteria used in 170 placebo-controlled antidepressant efficacy trials (AETs) that were published between 1995 and 2014. In conducting this literature review, we identified a number of instances in which the descriptions of the inclusion/exclusion criteria were vague, redundant, or difficult to interpret. In the present article, we describe nine problems we encountered in our literature review. We recommend that future publications follow the examples found in a few studies in which the inclusion/exclusion criteria are clearly defined and listed in a table.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s40263-016-0314-y | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!